• Hyperliquid Strategies posted net profit of $152.5 million for quarter ended March 31, 2026, swinging from net loss of $165.4 million for nine months ended March 31, 2026.
• Staking revenue came in at $2.6 million, interest income totaled $1 million, SG&A and R&D expenses were $7.2 million.
• Total assets were $809.4 million at quarter-end, including $689 million in HYPE tokens and $113.1 million in cash and cash equivalents; stockholders’ equity was $743.5 million with no debt.
• Treasury rose to 20 million HYPE tokens as of April 29 with $103 million cash remaining, following $216 million deployed to accumulate about 7.3 million HYPE tokens since inception.
• CEO David Schamis cited scaling HYPE holdings, a validator partnership with Unit Labs, and disposition of most legacy bio-tech operations, while pointing to HIP-3 RWA perps, portfolio margin, and outcome markets as potential growth drivers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperliquid Strategies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605071615PR_NEWS_USPR_____NY54201) on May 07, 2026, and is solely responsible for the information contained therein.